Larvol Delta - Biolexis-Therapeutics-launches-subsidiary-Metabolexis-to-develop-novel-oral-medicines-for-Obesity-and-Type-2-Diabetes-to-improve-human-longevity

MLX 0800 - Biolexis Therap

MLX 5000 - Biolexis Therap

MLX 7000 - Biolexis Therap

https://www.prnewswire.com/news-releases/biolexis-therapeutics-launches-subsidiary-metabolexis-to-develop-novel-oral-medicines-for-obesity-and-type-2-diabetes-to-improve-human-longevity-301968415.html

Oct 26, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next